Neuroimmunomodulation by gut bacteria: Focus on inflammatory bowel diseases

doi:10.4291/wjgp.v12.i3.25

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7811)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

471

WORD

209

HTML

3588

Figures (1-3)

341

Tables (1-1)

376

Sum=4985

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

356

Download

866

Sum=1222

Publishing Process of This Article

Item

Count

Browse

506

Download

1098

Sum=1604

May 22, 2021 (publication date) through Aug 14, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pathophysiology

ISSN

2150-5330

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastrointest Pathophysiol. May 22, 2021; 12(3): 25-39
Published online May 22, 2021. doi: 10.4291/wjgp.v12.i3.25

Full Size Figure Download Figure

Figure 2 Inter-relation of diverse gut microbiota and their respective neuromediators with gut inflammation. Bacteria used as probiotics in inflammatory bowel disease (IBD) (green box) produces anti-inflammatory neuromediators (γ-aminobutyric acid, acetylcholine), bacteria having a detrimental role in IBD (purple box) releases pro-inflammatory neuromediator (serotonin) and bacteria having a debatable role in IBD (blue box) secrete neuromediator (noradrenaline) having both pro and anti-inflammatory properties. GABA: γ-aminobutyric acid.

Citation: Aggarwal S, Ranjha R, Paul J. Neuroimmunomodulation by gut bacteria: Focus on inflammatory bowel diseases. World J Gastrointest Pathophysiol 2021; 12(3): 25-39
URL: https://www.wjgnet.com/2150-5330/full/v12/i3/25.htm
DOI: https://dx.doi.org/10.4291/wjgp.v12.i3.25